CNBC logo

Crispr, Hep C treatment, PrEP

When it came to biomedical breakthroughs, this past decade represented a lot more hype than substance. We were promised a new era of “precision medicine,” where every patient would receive highly personalized treatments to target specifics fault in their genes. But in recent months, reports surfaced that these experimental therapies were failing most of the … Read more…